X-Gen Pharmaceuticals Inc. has recalled 720 units of Neomycin Sulfate Tablets, USP 500mg, because the medication failed stability specifications during a microbiological assay. This means the drug may not maintain its required potency or quality through its expiration date. Neomycin sulfate is a prescription antibiotic typically used to reduce the risk of infection during surgery or to treat certain hepatic conditions. Consumers should be aware that about 720 100-count blister packs are affected and were distributed nationwide.
The drug failed a microbiological assay, which indicates the product may not meet its required purity or strength standards over time. If a medication is less effective than expected, it could lead to untreated infections or inadequate preparation for surgical procedures.
Healthcare consultation and refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.